oncology

How can AI-based auto-contouring improve the life of patients who need palliative radiation therapy?
Cancer is one of the leading causes of morbidity and death, worldwide. Approximately 18 million people are diagnosed with cancer each year and the number…
Clinical User Experience with MVision AI
This is a webinar that you don’t want to miss! You’ll hear from an actual user and their clinical experience with MVision’s AI-powered software. Please…
Advancements in Breast Cancer Treatment: Highlights from the ESTRO 2023 Conference
The annual meeting of the European Society for Radiotherapy and Oncology (ESTRO) took place in Vienna from 12 to 15 May, gathering over 6000 professionals.…
Radiotherapy for Esophageal Cancer – The Challenge of a Difficult Site
More than half a million people are diagnosed each year with esophageal cancer. It is the 8th most common cancer type and places sixth regarding…
Press Release: MVision AI raises 5.4M€ to make same-day cancer treatment the new standard
HELSINKI, Finland – March 23, 2023 MVision AI raises 5.4M€ to make same-day cancer treatment the new standard MVision AI is the first cloud-based AI-powered…
MVision AI: your data is protected!
MVision AI not only provides unique AI-powered solutions for Radiotherapy treatment planning but also follows the highest standards of data protection for clinics and their…
MVision AI Receives FDA 510(k) Clearance for Guideline-Based Segmentation Radiotherapy Software
Helsinki, 31st of May, 2022 – MVision AI announces that it received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for guideline-based, AI-powered…
2021 MVision AI Re-cap: The Year of GCAIS™
2021 is an innovative and  foundational year for MVision AI. We are proud of what we have accomplished so far and super excited about what…
Guideline-Based Radiotherapy Auto-Segmentation Services in Switzerland
During 2020, there were over 60,000 new cancer cases and over 19,000 cancer-related deaths in Switzerland. In fact, Switzerland’s Federal Statistics Office found that, “more…